Written by Travis Rodgers | Edited by Amy Edel
A Massachusetts judge is reducing the $39 million verdict awarded in September 2024 in a groundbreaking talc pleurodesis mesothelioma lawsuit. A significant portion of the original amount the jury awarded to Bryce Zundel was $21.5 million for future pain and suffering. The judge reduced that amount to $6 million, making the new total awarded to Zundel $23.6 million.
The judge upheld the jury’s verdict against defendant Georgia-based talc supplier Cimbar Performance Minerals. He said he found no reason to overturn the jury’s decision. But he found Zundel’s original future pain and suffering award to be “greatly disproportionate” to the jury’s findings. He said the reduced amount was reasonable given the evidence presented in the case.
Zundel was diagnosed with mesothelioma in 2021 after undergoing a pleurodesis in 2014. His lawsuit argued the talcum powder used in his procedure was contaminated with asbestos. The defendant imported the talc used in Zundel’s procedure from China.
Doctors perform pleurodesis to address and prevent pleural effusions in mesothelioma patients. Medical-grade talc is injected into the pleural space to prevent fluid or air buildup. Zundel’s pleurodesis involved injecting sterile talcum powder around his left lung.
As attorney Danny Kraft with Meirowitz & Wasserberg tells us, “They covered his left pleural surface with talc, and that’s the exact location where he developed mesothelioma. This isn’t a coincidence.”Kraft added, “This is a scientific fact that this product contaminated with asbestos caused the disease.” Asbestos is the primary cause of mesothelioma.
When filing a mesothelioma lawsuit, the right legal representation is everything. We’ll connect you to a top lawyer who will help you secure financial compensation.
File a LawsuitZundel’s case is the first lawsuit and verdict in a mesothelioma lawsuit stemming from talc used during pleurodesis. With approximately 100,000 pleurodesis procedures performed in the U.S. per year and talc the most commonly used agent, many patients may face the risk of asbestos exposure.
Kraft told us, “Patients like Bryce are sometimes missed. We didn’t want this case to be missed. We wanted his case to be living proof that when you inject asbestos into someone’s body, it causes this disease.”
He added, “Our hope is that nobody else has to suffer through the nightmare that Bryce and his family are living with. So that no one else ever receives this procedure, that no one else suffers this fate.”
Lawyers obtained a 5-gram sample of the talc used in Zundel’s procedure. A doctor tested the talc and found it was contaminated with tremolite and chrysotile asbestos.
Kraft recounted, “We were able to show that this product contained asbestos. One of the interesting facts of this case is they imported millions of pounds of this stuff into the country. We were able to show the jury that the defendant knew asbestos was a carcinogen before they ever imported it.”
“One of the themes of our case was, if you know it’s a hazard, if you know it causes cancer, then you have to do more than just test a thimble full to ensure that this product is completely clean – particularly when you know it’s going to be used for a medical procedure,” Kraft commented. “And they didn’t do that.”
Mesothelioma cases usually involve plaintiffs who received a mesothelioma diagnosis decades after their initial exposure to asbestos. The latency period for mesothelioma, or the time between the initial exposure and the onset of symptoms, is 20 to 60 years.
Zundel was diagnosed 7 years after his talc pleurodesis procedure. His short latency period posed a unique challenge.
“Everyone said this is an impossible case because of the short latency period,” Kraft shared with us. “Because it was the first lawsuit involving someone having talc pleurodesis develop into mesothelioma.”
As Kraft noted, “It wasn’t an inhalation case.” Most asbestos litigation involves occupational exposure or secondhand exposure involving inhalation of asbestos fibers on or brought home from job sites.Zundel’s medical exposure case raises awareness about other possible forms of asbestos exposure. Kraft hopes Zundel’s case will have a lasting impact on the medical community.
Stay up-to-date on treatment, research, clinical trials, doctors and survivors
The information on this website is proprietary and protected. It is not a substitute for professional medical advice, diagnosis or treatment. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our privacy policy and terms of service for more information about our website.
This website and its content may be deemed attorney advertising. Prior results do not predict a similar outcome.
The Mesothelioma Center’s claim as the most trusted resource is based on our more than 150 5-star Google and BBB reviews. Our organization also helps more than half of all mesothelioma patients annually diagnosed.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.LashawnMesothelioma patient’s daughter
Asbestos.com. (2026, February 12). Talc Pleurodesis Award Reduced From $39M to Nearly $24M. Retrieved February 27, 2026, from https://www.asbestos.com/news/2024/09/25/talc-pleurodesis-mesothelioma-case/
"Talc Pleurodesis Award Reduced From $39M to Nearly $24M." Asbestos.com, 12 Feb 2026, https://www.asbestos.com/news/2024/09/25/talc-pleurodesis-mesothelioma-case/.
Asbestos.com. "Talc Pleurodesis Award Reduced From $39M to Nearly $24M." Last modified February 12, 2026. https://www.asbestos.com/news/2024/09/25/talc-pleurodesis-mesothelioma-case/.
Travis Rodgers is an Emmy-nominated journalist with more than two decades of experience in television news. He held many roles in broadcasting, but spent most of his time as a producer crafting live newscasts for multiple network affiliates. Travis now brings his many years of writing experience to Asbestos.com.
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.
